Supreme Court Damage Lawsuit Withdrawn via Settlement - 17.8 Billion Won Settlement and Convertible Bond Issuance
- Withdrew the Supreme Court appeal (2026Da202990) for damages and reached a settlement with the counterparty (Biovill in rehabilitation)
- Pays 17.8 billion won in cash from a deposit and issues 7.4 billion won in convertible bonds as additional settlement
- Acquires approximately 1.56 million shares of Korea Stem Cell Bank held by counterparty for 3.5 billion won cash, and an additional 3.94 million shares via 8.9 billion won convertible bond issuance
- Lost at appellate court (Seoul High Court) with a judgment of 17.5 billion won plus delay damages, but settled for a smaller total amount
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Other Management Matters (Voluntary Disclosure) (Supreme Court 2026 Da 202990 Damage Compensation (Basic) Lawsuit Withdrawal Agreement Conclusion)
- Company: GemVax & KAEL (082270)
- Submission: GemVax & KAEL Co.,Ltd.
- Receipt: 04-28-2026
- Under KRX KOSDAQ Market Division